CAPTOPRIL

Captopril is an ACE inhibitor reducing angiotensin II formation, lowering blood pressure and improving heart function. Side effects include cough, dizziness, and hyperkalemia.

SKU: 34889c8cd10c Category: Tag:

Product Description


Mechanism of action

Captopril is an angiotensin‑converting enzyme (ACE) inhibitor that prevents conversion of angiotensin I to angiotensin II. This reduces vasoconstriction, aldosterone release, sympathetic outflow and sodium retention. It also inhibits bradykinin degradation, enhancing vasodilation via nitric oxide and prostaglandin pathways. Its sulfhydryl group contributes to potent ACE inhibition.

Benefits and advantages

Used in cardiovascular research, RAAS‑pathway modelling, hypertension studies, heart‑failure investigations, endothelial‑function experiments and ACE‑inhibitor SAR analysis. Also used to examine renoprotective mechanisms in diabetic nephropathy.

Side effects and risks

Risks include cough, hypotension, hyperkalaemia, angioedema, renal impairment and rash. Handle with antihypertensive‑active compound precautions.

Datasheet


Molecular Formula

C9H15NO3S

Molecular Weight

217.29 g/mol

CAS Number

5747-74-2

Storage Condition

Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.

Solubility

Freely soluble

Purity

Purity information is available upon request (COA).

Synonym

captopril; 62571-86-2; Capoten; L-Captopril; Captopryl

IUPAC/Chemical Name

(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

InChl Key

FAKRSMQSSFJEIM-RQJHMYQMSA-N

InChl Code

InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/44093;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download